DLC1 and lung carcinoma: This reduced DLC1 activity in human lung cancer was attributable to AKT and SRC kinase activities, both of which reduce the tumor suppressor activity of DLC1 via direct phosphorylation of specific tyrosines by SRC and specific serines by AKT28.